Samsung Biologics (207940) Insider Transactions

🇰🇷 South Korea 🏛 Korea Exchange 📋 FSC/FSS 🔄 Updated daily 🟢 Recently active

The most recent insider transactions at Samsung Biologics include purchases filed with FSC/FSS under MAR Article 19. In November 2026, Jon Rim (CEO) bought 12 shares worth ₩14M.

Last updated: 2026-11-20 · Data sourced from MAR Article 19 regulatory disclosures

9
Total Transactions
3
Insider Buys
6
Insider Sells
2 days ago
Last Activity

🔔 Get alerts for Samsung Biologics

Be notified when insiders buy or sell Samsung Biologics. Free for up to 3 stocks.

Recent Insider Transactions at Samsung Biologics

DateInsiderRole TypeSharesPriceValueSignals
2026-11-17 Jon Rim CEO BUY 12 ₩1M ₩14M —
2026-11-17 No Gyun President BUY 2 ₩1M ₩2M —
2026-11-17 Yu Seungho President BUY 6 ₩1M ₩7M —
2026-11-03 Gim Huijeong Executive Director SELL 10 ₩272,600 ₩3M —
2026-11-03 Je Imseuchoe President SELL 25 ₩295,000 ₩7M —

Showing last 5 transactions · View all in app →

See all Samsung Biologics insider transactions in real-time

Live filings with conviction scores, signal badges, and post-trade return tracking.

View Live Data →

Insiders Tracked at Samsung Biologics

JR
Jon Rim
CEO
1 filing · 1 buy
NG
No Gyun
President
1 filing · 1 buy
YS
Yu Seungho
President
1 filing · 1 buy
GH
Gim Huijeong
Executive Director
1 filing · 0 buys
JI
Je Imseuchoe
President
1 filing · 0 buys

About This Data

InsidersAlpha tracks insider transactions at Samsung Biologics filed with FSC/FSS under MAR Article 19. Data is sourced directly from official regulatory filings and updated daily. All 9 transactions on record include 3 insider purchases and 6 sales.

The largest single transaction recorded was worth ₩74M by Jo Seonghwan on 2026-07-31.

Frequently Asked Questions

Who are the insiders trading Samsung Biologics stock?

Known insiders at Samsung Biologics include Jon Rim (CEO), No Gyun (President), Yu Seungho (President), Gim Huijeong (Executive Director), Je Imseuchoe (President). InsidersAlpha tracks 5 named insiders at Samsung Biologics.

When was the last insider buy at Samsung Biologics?

The most recent insider purchase at Samsung Biologics was by Jon Rim (CEO) on 2026-11-17, buying 12 shares at ₩1M for a total of ₩14M. InsidersAlpha updates daily from official FSC/FSS disclosures.

How many insider transactions has Samsung Biologics had?

Samsung Biologics has had 9 insider transactions tracked on InsidersAlpha, including 3 purchases and 6 sales. The overall buy/sell ratio is 33% buys.

What is the insider buying trend at Samsung Biologics?

Over the past 6 months, Samsung Biologics insiders have made 3 purchases totaling ₩23M. The insider activity trend is mixed — showing both buying and selling (3 buys vs 6 sells). Past performance does not guarantee future results — always conduct your own research.

Related Pages